Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

CVS Health Corp (NY: CVS )

65.75 +0.91 (+1.40%)
Official Closing Price Updated: 7:00 PM EDT, Mar 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CVS Health Corp

< Previous 1 2
...
10 11 12 13 14 15 16 17 18
...
53 54 Next >
3 High-Yield S&P 500 Dividend Stocks Down More Than 25% to Buy Now and Hold for at Least a Decade
Their prices might not be done falling, but you can count on the dividends they distribute to continue rising steadily. 
Via The Motley Fool
Topics Stocks
Exposures US Equities
CVS ALERT: Bragar Eagel & Squire, P.C. is Investigating CVS Health Corporation on Behalf of CVS Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Maximize Profits with These 3 Discounted Stocks Set to Skyrocket
These discounted stocks are positioned to provide substantial returns to investors given their strong growth potential. 
Via InvestorPlace
Is CVS Health Stock a Millionaire Maker?
The stock's low valuation today could set up investors for oversized gains in the future. 
Via The Motley Fool
CVS Health's Options Frenzy: What You Need to Know
Via Benzinga
CVS Health Unusual Options Activity For June 05
Via Benzinga
Looking Into CVS Health's Recent Short Interest
Via Benzinga
CVS Health's Options Frenzy: What You Need to Know
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Top 3 Bargain Stocks to Watch Near Their 52-Week Low Prices
Three stocks come to give investors a chance to beat stagflation, analysts think all of these could rise by double-digits in the coming months. 
Via MarketBeat
Topics Economy
Exposures COVID-19 Economy Interest Rates
AbbVie's Arthritis Drug Humira Retains Market Dominance Despite Biosimilar Competition, Challenges Biosimilar Industry Viability
Humira maintains over 80% of its market share despite facing nine biosimilar rivals, raising concerns about the future of the biosimilar market and prompting calls for regulatory reform to enhance... 
Via Benzinga
How To Earn $500 A Month From CVS Health Stock
CVS Health currently has a dividend yield of 4.38%, which is a quarterly dividend amount of 66.5 cents a share ($2.66 a year). 
Via Benzinga
Check Out What Whales Are Doing With CVS
Via Benzinga
What Analysts Are Saying About CVS Health Stock
Via Benzinga
7 Deeply Discounted Stocks With 100%+ Upside Potential
These deeply discounted stocks in various sectors have compelling turnaround stories and could potentially double or triple in value. 
Via InvestorPlace
Dividend Aristocrats on Sale: 3 Discounted Stocks to Snap Up Now
Bet on these three best discounted dividend aristocrats, known for 25+ years of rising dividends while offering healthy upside. 
Via InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
The S&P 500 Is at Record Levels but These 3 Stocks Are Still Near Their 52-Week Lows
These stocks are all down more than 15% this year. 
Via The Motley Fool
Topics Stocks
Exposures US Equities
Are Boomers Crashing The Economy Or Saving It? Why Investors Are Perplexed And What You Can Do To Prepare
Mass retirement of boomers could have major economic impact. Experts anticipate both risks and opportunities from the largest wealth transfer in history. 
Via Benzinga
Topics Economy Retirement
Exposures Economy Pension
3 Sorry Healthcare Stocks to Sell in May While You Still Can
Steer clear of these three companies facing significant challenges. Discover why these are risky healthcare stocks to sell. 
Via InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
2 Beaten-Down Dividend Stocks to Buy and Hold For 10 Years
These companies have grown their dividends despite some troubles. 
Via The Motley Fool
Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 4% Dividend Yields
Via Benzinga
Is Cigna Group the Nation's Best-Run Health Insurance Company?
Cigna looks like a shining star as many health insurance companies fare poorly in 2024 due to higher Medicare Advantage (MA) expenses 
Via MarketBeat
3 Dividend Stocks For My Birthday
Celebrating a birthday can be about more than just cake and candles—it can also be an excellent opportunity to review one's investment portfolio. 
Via Talk Markets
Want $1,000 in Dividend Income? Here's How Much You'd Have to Invest in CVS Stock.
CVS shares plunged following its latest earnings report. Is it a buy? 
Via The Motley Fool
MarketBeat Week in Review – 5/20 - 5/24
The market sold off sharply despite a strong earnings report from Nvidia; a short trading week will include economic reports that could bring more volatility 
Via MarketBeat
Topics Economy Stocks
Exposures Economy US Equities
From Zero to Hero: 3 Stocks Poised for an Epic Rebound
Discover three rebound stocks to buy with significant growth potential and lucrative returns in communication, financials and healthcare. 
Via InvestorPlace
CVS Health Seeks Private Equity Partner for Oak Street Health Expansion
CVS Health seeks a private equity partner to fund the expansion of Oak Street Health, acquired for $10.6 billion. This joint venture aims to open new clinics, easing initial losses and protecting CVS's... 
Via Benzinga
8 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
< Previous 1 2
...
10 11 12 13 14 15 16 17 18
...
53 54 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback